According
to a new market report published by Transparency Market Research “SNP Genotyping and Analysis Market
(GeneChips, Taqman Allelic Discrimination, Pyrosequencing, AB SNPlex, Sequenom MassARRAY
MALDI-TOF): Global Industry Analysis, Size, Share, Growth, Trends and Forecast,
2013 – 2019,” the global SNP genotyping and analysis market was
valued at USD 2,385.2 million in 2012 and is expected to grow at a CAGR of 21.8%
from 2013 to 2019, to reach an estimated value of USD 9,485.2 million by 2019.

SNPs
are the most commonly occurring genetic mutations that can be observed in a
genome. These are responsible for a person’s traits that include strengths and
weaknesses. These variations also lead to changes in crop yield, meat and dairy
yield among several other factors. The report evaluates the SNP genotyping
market which is an aggregate of three facets, instrumentation, reagents or
consumables, and services. After the Human Genome Project was concluded a need
for faster and cheaper sequencing methods were realized that led to
revolutionary changes and eventually ended in vertical drop in sequencing
costs. Increasing global gene banks and databases have initiated a series of
research and development projects to understand potential of developing
diagnostic tests through rapid genotyping techniques.

The
market can be perceived to be divided into instruments, reagents or consumables
and software and services. Since several technologies in the market are still
in the nascent phase, the instruments segment accounts for the largest share as
of today but this is expected to change as larger quantities of consumables are
used in coming years. The market growth for older systems rises mainly from
reagents and consumables as there is low involvement of specialized
instrumentation or technologies. The market is expected to decrease further as
efforts are initiated to introduce new technologies in these regions and phase
out the slower and less efficient methods that are time consuming.

North
America accounted for the largest market share in 2012 amongst other regions
that included Europe, Asia-Pacific and Rest of the World. Europe’s unstable
economy has continued to torment the genomics market which SNP genotyping is a
part of. Increasing demand from services, animal breeding and livestock,
decreasing cost of products and services should encourage the growth of the
market in coming years. Asia-Pacific and several countries in RoW region are
expected to hold the largest potential in forecast period in terms of revenue.
The competitive landscape is oligopolistic. There are leaders in individual
market segments, yet in terms of overall popularity; Life Technologies
Corporation, Illumina Inc., Affymetrix Inc, Fluidigm, Sequenom and Roche are
established to be the key vendors operating in this market.

The
global SNP genotyping and analysis market is segmented into the following
categories:

Transparency
Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insight for thousands
of decision makers. Our experienced team of Analysts, Researchers, and
Consultants, use proprietary data sources and various tools and techniques to
gather, and analyze information.

Our
data repository is continuously updated and revised by a team of research
experts, so that it always reflects the latest trends and information. With a
broad research and analysis capability, Transparency Market Research employs
rigorous primary and secondary research techniques in developing distinctive
data sets and research material for business reports.